Benzinga | Aug 3, 2021 08:10AM EDT

Pacira BioSciences Q2 EPS $0.77 Beats $0.69 Estimate, Sales $135.60M Beat $128.01M Estimate

Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.77 per share which beat the analyst consensus estimate of $0.69 by 11.59 percent. This is a 541.67 percent increase over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $135.60 million which beat the analyst consensus estimate of $128.01 million by 5.93 percent. This is a 79.59 percent increase over sales of $75.50 million the same period last year.